CeceliaHBoardmanMD
Obstetrics & Gynecology • Richmond, VAGynecologic Oncology, Hospice & Palliative Medicine
Associate Professor of Obstetrics & Gynecology, Va Commonwealth University School of Medicine
Dr. Boardman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7603 Forest Ave
Ste 207
Richmond, VA 23229Phone+1 804-200-7062Fax+1 804-200-7063
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 1997 - 2000
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1992 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1992
Certifications & Licensure
VA State Medical License 2000 - 2024
MN State Medical License 1997 - 2000
PA State Medical License 1994 - 1998- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer Start of enrollment: 2011 Apr 04
- Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- 80 citationsPhase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.Alessandro D. Santin, Michael W. Sill, D. Scott McMeekin, Mario M. Leitao, Jubilee Brown
Gynecologic Oncology. 2011-09-01 - 424 citationsPhase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group StudyBradley J. Monk, Michael W. Sill, D. Scott McMeekin, David E. Cohn, Lois M. Ramondetta
Journal of Clinical Oncology. 2009-10-01 - 137 citationsPhase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic On...David Miller, John A. Blessing, Carolyn N. Krasner, Robert S. Mannel, Parviz Hanjani
Journal of Clinical Oncology. 2009-06-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
